KCNA3 and Parkinson disease: In contrast to the targets mentioned above and an off-target blockade of effects from xanthine oxidase/dehydrogenase, target-action pairs for carvedilol (adrenergic receptor and potassium channel blocking) were not inversely associated with PD, AD, or ALS.